현금 및 동등한 변화 날짜
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amgen USD 9.13B 316M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cytokinetics USD 122.52M 102.95M 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Novartis USD 11.44B 1.88B 2025-12
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
TG Therapeutics USD 199.51M 21.2M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xencor USD 54.07M 25.78M 2025-12